Searchable abstracts of presentations at key conferences in endocrinology

ea0031p218 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Weight loss after bariatric surgery in women of childbearing age

Alatishe Aderinsola , Ammori Basil J , New John P , Syed Akheel A

Obesity increases the risk of pregnancy-related complications such as miscarriage, foetal abnormalities, hypertension, diabetes, thrombosis, caesarean section and infection. Although bariatric surgery addresses some of these risks, women should defer pregnancy for 12-24 months postoperatively until weight loss has plateaued due to concerns regarding limited maternal weight loss and foetal nutritional deficiency. The aim of this study was to evaluate the impact of pregnancy on ...

ea0021p161 | Diabetes and metabolism | SFEBES2009

Weight and glycaemic outcomes following bariatric surgery in people with type 2 diabetes

Demssie Yared N , Jawaheer Jhalini , Farook Seleena , New John P , Syed Akheel A

Bariatric surgery in people with morbid obesity results in effective long-term weight loss, and resolution or reduction in the severity of several co-morbid conditions. The majority of obese people with type 2 diabetes who undergo bariatric surgery, achieve remission of their diabetes or a significant reduction of their glucose lowering therapy in the long-term. We conducted a retrospective observational study to assess changes in body weight and glycaemic control in obese typ...

ea0050p337 | Obesity and Metabolism | SFEBES2017

Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obese patients with and without diabetes

Dhage Shaishav Shashikant , Adam Safwaan , Ho Jan Hoong , Yadav Rahul , Hama Salam , Schofield Jonathan , France Michael , Syed Akheel A , Siahmansur Tarza , Pemberton Philip , Aghamohammadzadeh Reza , Donn Rachelle , Malik Rayaz A , New John P , Durrington Paul , Ammori Basil A , Liu Yifen , Soran Handrean

Background: Obesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes.Aims: To evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with a...

ea0050p337 | Obesity and Metabolism | SFEBES2017

Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obese patients with and without diabetes

Dhage Shaishav Shashikant , Adam Safwaan , Ho Jan Hoong , Yadav Rahul , Hama Salam , Schofield Jonathan , France Michael , Syed Akheel A , Siahmansur Tarza , Pemberton Philip , Aghamohammadzadeh Reza , Donn Rachelle , Malik Rayaz A , New John P , Durrington Paul , Ammori Basil A , Liu Yifen , Soran Handrean

Background: Obesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes.Aims: To evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with a...